H2 Life Foundation organised a Round-Table Discussion on “Make in India: Generic Drugs and the big opportunity in the Indian Pharma Sector”. Mr. Vikas Sharma, President, H2 Life Foundation was the convener of the discussion.
Mr Ranjit Madan, CEO, Life Sciences Sector Skill Development Council, was the special guest at the discussion. With respect to the New Pharma Policy he stated “Emphasis should be laid on integrating the programmes under Skill India with the objectives of the ‘Make in India’ initiative to give a boost to domestic production and provide support to the pharmaceutical sector”.
Addressing the gathering at the discussion, Mr. Vikas Sharma stressed that “Special attention and support should be given to R&D endeavours and the development of new manufacturing facilities. Issues like the lack of investments and funding, sharing of pharmaceutical infrastructure and the development of a skilled workforce need to be addressed on a priority basis”.
The Round-Table Discussion was a huge success and witnessed participation of key stakeholders from varying fields which included Members of Parliament, corporates, hospitals, pharmaceutical companies and consultants, diplomats, think-tanks, and media personnel. The panelists included: Dr. Rakesh Garg, Consultant Anesthesiologist and Associate Professor, AIIMS; Dr Anil Goyal, Hon. Joint Secretary, Indian Medical Association; Dr. Ajay Sharma, Director-Government Affairs, OPPI; P K Gupta, Chairman, Confederation of Indian Pharmaceutical Industry; Ashok Kumar Madan, Executive Director, Indian Drug Manufacturers Association; Dr. R.K. Aggarwal, Director, Bureau of Pharma Public Sector Undertakings of India (BPPI); Vipul Kumar Gupta, Corporate Affairs, Cipla; Dr. Sanjeev Sharma, MD, MCP, Apollo Pharmacy amongst others.